L. Antón

Original article: Combination chemotherapy with cisplatin and 5-fluorouracil 5-day infusion in the therapy of advanced gastric cancer: A Phase II trial

E. Esteban, A. Lacave, I. Palacio, 1991 .

Novel potential predictive markers of sunitinib outcomes in long-term responders versus primary refractory patients with metastatic clear-cell renal cell carcinoma

E. Gallardo, J. Maroto, E. Esteban, 2017, Oncotarget.

Combination chemotherapy with cisplatin and 5-fluorouracil 5-day infusion in the therapy of advanced gastric cancer: a phase II trial.

E. Esteban, A. Lacave, I. Palacio, 1991, Annals of oncology : official journal of the European Society for Medical Oncology.

Phase II study of carboplatin and 1-h intravenous etoposide and paclitaxel in a novel sequence as first-line treatment of patients with small-cell lung cancer.

C. García-Girón, E. Esteban, R. López, 2003, Lung cancer.

Gemcitabine plus docetaxel as first-line chemotherapy in patients with advanced non-small cell lung cancer: a lung cancer Galician group phase II study

R. López-López, J. Tisaire, M. Constenla, 2007, Cancer Chemotherapy and Pharmacology.